MPI 5017

Drug Profile

MPI 5017

Alternative Names: Vinblastine/epinephrine injectable gel

Latest Information Update: 15 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chiron Corporation
  • Class Antineoplastics
  • Mechanism of Action Tubulin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Solid tumours

Most Recent Events

  • 13 Jun 2001 No-Development-Reported for Solid tumours in USA (Intratumoural)
  • 07 Jan 1999 Suspended-Preclinical for Solid tumours in USA (Intratumoural)
  • 02 Jul 1998 No-Development-Reported for Solid tumours in USA (Intratumoural)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top